The Economic Burden of Pneumonia in Canada: A Status Quo Forecast

The Conference Board of Canada, 26 pages, April 10, 2017
Briefing by
5.0/5 based on 1 review
(You must be signed in and entitled to rate this report)
This briefing estimates the future economic burden of pneumonia in Canada up to 2025 for the population aged 65 and over.

Document Highlights

Pneumonia is an acute respiratory disease caused by either bacterial or viral infection. It is most prevalent among children and the elderly, due to their lower immune system functions. Although pneumonia is normally treated after the discovery of the symptoms, both viral and bacterial pneumonia can be prevented proactively by vaccination. Hospitalized pneumonia costs the Canadian health care system hundreds of millions of dollars per year. As the Canadian population continues to grow and age, there are concerns about the increase in disease burden over time if preventative measures that promote and strengthen population immunity, such as vaccination, are not achieved.

This briefing estimates the future economic burden of pneumonia in Canada by examining trends in disease incidence, estimating and quantifying the current burden, and forecasting expected burden to the year 2025 for those aged 65 years and older.

Access document

(you will be asked to sign-in)

Price: $0
You can get this research for free. Take a minute and create an e-Library account.